Clinical Trials on Therapeutic Equivalency, Healthy in United Kingdom

Total 8748 results

Janssen Sciences Ireland UC

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ 53718678 in Healthy Japanese Adult Participants

Healthy

United Kingdom
Daiichi Sankyo, Inc.

Completed

Multiple Dose Study of D1971a in Healthy Volunteers

Healthy

United Kingdom
Takeda

Completed

Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous Administration

Healthy

United Kingdom
Eli Lilly and Company

Completed

Study of LY3039478 in Healthy Participants

Healthy

United Kingdom
PharmAkea, Inc.

Completed

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of PAT-1251 in Healthy Adult Subjects

Healthy

United Kingdom
Ardea Biosciences, Inc.
Quotient Clinical

Completed

IVIVR Assessing PK Parameters Used to Establish Bioequivalence

Healthy

United Kingdom
University of Nottingham

Completed

Effects of Bread Gluten Content on Gastrointestinal Volumes (EGG)

Healthy

United Kingdom
Nabriva Therapeutics AG

Completed

Bioavailability and Pharmacokinetics of Lefamulin When Administered to Fed and Fasted Healthy Subjects

Healthy

United Kingdom
Janssen Infectious Diseases BVBA

Completed

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-63623872 in Healthy Japanese Adult Participants

Healthy

United Kingdom
University of Nottingham
Physiological Society

Completed

The Implementation of Novel 'Heavy' Water Techniques for Determining Modulation of Muscle Protein, DNA and Lipid Synthesis Due to Ageing

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Investigating the Absorption, Metabolism and Excretion (AME) of Idalopirdine

Healthy

United Kingdom
AstraZeneca

Completed

Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects

Healthy

United Kingdom
Gedeon Richter Plc.

Completed

A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

Healthy

United Kingdom
Biogen

Completed

BG00012 Regional Absorption Study

Healthy

United Kingdom
Celtaxsys, Inc.

Completed

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics and Safety of CTX 4430 and Midazolam

Healthy

United Kingdom
AstraZeneca

Completed

Healthy Volunteers, Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] AZD8931

Healthy

United Kingdom
Boehringer Ingelheim

Withdrawn

A Study to Investigate the Phototoxic Potential of Faldaprevir

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Absolute Bioavailability of Lu AE58054 in Healthy Subjects

Healthy

United Kingdom
LEO Pharma

Completed

LEO 27847 - Single Dose Bioavailability Study of Oral Solution Versus Tablet in Healthy Subjects

Healthy

United Kingdom
LEO Pharma

Completed

LEO 27847 - A Study in Healthy Male Subjects

Healthy

United Kingdom
MerLion Pharmaceuticals GmbH

Completed

Safety and Tolerability of Single and Multiple Intravenous Doses of Finafloxacin in Healthy Subjects

Healthy

United Kingdom
University of Nottingham

Completed

Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption

Healthy

United Kingdom
Labopharm Inc.

Completed

A Comparative Bioavailability/Food Effect Study of Immediate-Release and Extended-Release Tramadol HCl/Acetaminophen Combination Products Following Single-Dose and Multiple-Dose Administration in Healthy Adult Volunteers

Healthy

United Kingdom
AstraZeneca

Completed

Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305 (2007-005765-38)

Healthy

United Kingdom
AstraZeneca

Completed

Study to Investigate the Activity of AZD5122 When Given as a Single Dose to Healthy Male Subjects

Healthy

United Kingdom
Novartis

Completed

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

Healthy

United Kingdom
University of Arkansas
Mount Sinai Hospital, Chicago

Terminated

Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation (loxapine)

Agitation,Psychomotor | Haloperidol Causing Adverse Effects in Therapeutic Use | Lorazepam Causing Adverse Effects in Therapeutic Use | Loxapine Causing Adverse Effects in Therapeutic Use

United States
University of North Carolina, Chapel Hill
North Carolina Translational and Clinical Sciences Institute

Recruiting

The Validation Study of Bioelectronics

Healthy | Health Behavior

United States
Octapharma

Completed

Octaplas Pediatric Plasma Exchange Trial (Octaplas)

Adverse Effects in the Therapeutic Use of Plasma Substitutes

United States
Imperial College London

Recruiting

Closed-loop Control of Penicillin Delivery (CLCPD)

Healthy Volunteers

United Kingdom
Eisai Limited

Completed

A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of Carbon-14 (14C)E7386 in Healthy Male Participants

Healthy Volunteers

United Kingdom
Bristol-Myers Squibb

Completed

A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Participants

Healthy Volunteers

United Kingdom
Xenon Pharmaceuticals Inc.

Completed

Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.

Healthy Volunteers

United Kingdom
Moleculin Biotech, Inc.

Completed

Study to Assess the Safety and Pharmacokinetics of WP1122 in Healthy Volunteers

Healthy Volunteer

United Kingdom
AstraZeneca
Quotient Sciences

Completed

A Study to Investigate the Absolute Bioavailability, Absorption, Metabolism, Distribution and Excretion of [14C]AZD5363 (Capivasertib)

Healthy Volunteer

United Kingdom
H. Lundbeck A/S

Completed

A Brain Imaging PET Study of [11C]-Lu AF88370 in Healthy Adult Male Participants

Healthy Participants

United Kingdom
Incyte Corporation

Completed

A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB086550

Healthy Volunteers

United Kingdom
Aristea Therapeutics, Inc.

Completed

A Study of the ADME of [14C]RIST4721 in Healthy Male Subjects

Healthy | ADME

United Kingdom
Tetraphase Pharmaceuticals, Inc.
PRA Health Sciences

Completed

Phase 1, Safety and Bronchopulmonary PK Study in Healthy Volunteers (BAL)

Healthy Subjects

United Kingdom
Celgene

Completed

A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

Healthy Volunteer

United Kingdom
Bristol-Myers Squibb

Completed

An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Healthy Male Participants

Healthy Participants

United Kingdom
Eisai Limited

Completed

A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants

Healthy Volunteers

United Kingdom
Boston Pharmaceuticals

Completed

Study to Determine the Single and Repeat Dose Pharmacokinetics, Food Effect, Proton Pump Inhibitor (PPI) Drug Interaction, Safety and Tolerability of Oral Prototype Formulations of BOS172767 in Healthy Subjects

Healthy Subjects

United Kingdom
Boston Pharmaceuticals

Completed

Study to Determine the Relative Bioavailability, Single and Repeat Dose Pharmacokinetics, Safety and Tolerability of BOS172767 Enantiomers in Healthy Subjects

Healthy Participants

United Kingdom
King's College London

Completed

The INTER-CARDIO Study: The Impact of Commonly Consumed Fat on Cardiovascular Health; a Randomised Controlled Trial (INTER-CARDIO)

Healthy Adults

United Kingdom
Imperial College London

Completed

Effect of Sucrose on Liver Fat

Healthy Volunteers

United Kingdom
Imperial College London
Malaysia Palm Oil Board

Completed

Effect of Palm Olein Intake on Lipid Profile and Fat Deposition (PalmOil)

Healthy Volunteers

United Kingdom
University of Exeter
King's College London; South London and Maudsley NHS Foundation Trust; Wesnes...

Completed

Online Grammatical Reasoning Training for Older Adults (START)

Healthy Aging

United Kingdom
MedImmune LLC

Completed

Phase 1 Single-ascending Dose Study to Evaluate Safety and Tolerability of MEDI4920 in Healthy Adults

Healthy Volunteer

United Kingdom
Pierre Fabre Dermatology

Withdrawn

Bioavailability Pilot Study of Versus W0035 Versus Stromectol

Healthy Volunteers

United Kingdom

3

Subscribe